Welcome Rebecca “Ribka” Berhanu, MD, as a new Assistant Professor in the Division of Infectious Disease!
September 30, 2021
Dr. Berhanu is an infectious diseases physician and clinical researcher. She is originally from Addis Ababa, Ethiopia. She completed her undergraduate degree at Stanford University and her medical degree at the Baylor College of Medicine. Ribka did her clinical training in internal medicine at the University of Chicago and her fellowship in infectious diseases at the University of North Carolina. She subsequently completed a post-doctoral fellowship at the Boston University School of Public Health.
New RePORT-Brazil publication: Determinants of losses in the latent tuberculosis infection cascade of care in Brazil
September 30, 2021
Determinants of losses in the latent tuberculosis infection cascade of care in Brazil publication was generated from the RePORT-Brazil collaboration, and published in BMJ Global Health
Introduction: Factors associated with losses in the latent tuberculosis infection (LTBI) cascade of care in contacts of patients with tuberculosis (TB) were investigated in a multicentre prospective cohort from highly endemic regions in Brazil.
New RePORT-Brazil publication: A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes
July 14, 2021
A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes scientific publication was generated from the RePORT-Brazil collaboration, led by Dr. Lauren Peetluk, and published in JID (Journal of Infectious Disease).
University of Washington's 4th Annual Advanced TB Research Training Course - Sept 13-17, 2021
July 14, 2021
The University of Washington's Department of Global Health and the Tuberculosis Research and Training Center (TRTC) are accepting applications for the 4th Annual Advanced TB Research Training Course. The course will be held as a Virtual Only course September 13 - 17, 2021.
New RePORT-Brazil publication: The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts
May 25, 2021
The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts scientific publication was generated from the RePORT-Brazil collaboration, led by Maria Arriaga, and published in JID (Journal of Infectious Disease).
Publication Announcement: “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis"
May 10, 2021
The U.S. Centers for Disease Control and Prevention (CDC) Tuberculosis Trials Consortium (TBTC), together with collaborators from the National Institutes of Health’s (NIH) AIDS Clinical Trial Group (ACTG), is pleased to announce the publication of “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis" in the New England Journal of Medicine.
Vanderbilt TB Center FY 2020 Annual Report has been released!
January 25, 2021
The TB Center Annual Report from FY 2020 has now been published, detailing Center activities, research, and funding for the 2020 fiscal year. See the link below to download the full report. We look forward to continued progress toward our research goals in the current year.
Landmark TB Trial Identifies Shorter-Course Treatment Regimen
October 21, 2020
Results from Study 31/A5349 were presented today at the Union World Conference on Lung Health. This study was conducted internationally through the Tuberculosis Trials Consortium (TBTC) and the AIDS Clinical Trials Group (ACTG) with funding from the CDC and NIH. Vanderbilt University Medical Center/Nashville Metro Public Health is a participating TBTC site, though did not enroll patients into this trial. April Pettit, VUMC faculty member, was a member of the protocol team.
From the CDC Press Release: